Go to a specific date

Explore

The Public Inspection page
on FederalRegister.gov
offers a preview of documents scheduled to appear in the next day's
Federal Register issue. The Public Inspection page may also
include documents scheduled for later issues, at the request
of the issuing agency.

Document Details

The meeting will be held on October 7, 2003, from 9 a.m. to 5 p.m., and on October 8, 2003, from 8:30 a.m. to 3:15 p.m.

Document Type:

Notice

Document Citation:

68 FR 56294

Page:

56294-56295
(2 pages)

Document Number:

03-24797

Document Details

Enhanced Content - Table of Contents

This tables of contents is a navigational tool, processed from the
headings within the legal text of Federal Register documents.
This repetition of headings to form internal navigation links
has no substantive legal effect.

Enhanced Content - Sharing

Enhanced Content - Document Print View

Enhanced Content - Document Print View

Enhanced Content - Document Tools

These tools are designed to help you understand the official document
better and aid in comparing the online edition to the print edition.

These markup elements allow the user to see how the document follows the
Document Drafting Handbook
that agencies use to create their documents. These can be useful
for better understanding how a document is structured but
are not part of the published document itself.

Enhanced Content - Developer Tools

Official Content

Official Content

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Office of the Secretary, HHS.

ACTION:

Notice of meeting.

SUMMARY:

As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (DHHS) is hereby giving notice that the National Vaccine Advisory Committee (NVAC) will hold a meeting. The meeting is open to the public.

DATES:

The meeting will be held on October 7, 2003, from 9 a.m. to 5 p.m., and on October 8, 2003, from 8:30 a.m. to 3:15 p.m.

SUPPLEMENTARY INFORMATION:

Pursuant to Section 2101 of the Public Service Act (42 U.S.C. 300aa-1), the Secretary of Health and Human Services was mandated to establish the National Vaccine Program (NVP) to achieve optimal prevention of human infectious diseases through immunization and to achieve optimal prevention against adverse reactions to vaccines. The Secretary designated the Assistant Secretary for Health to serve as the Director, NVP. The National Vaccine Advisory Committee (NVAC) was established to provide advice and make recommendations to the Director, NVP, on matters related to the program's responsibilities. Topics to be discussed at the meeting include: The Institute of Medicine's (IOM) vaccine safety reviews and the recent IOM report on vaccine financing; a status report on the nation's smallpox vaccine program, and an overview of the SARS vaccine research and development at the National Institutes of Health (NIH). Updates will be given on activities at the NIH's Vaccine Research Center, pandemic influenza preparedness planning, and a status report on the West Nile virus vaccine. A tentative agenda will be made available for review on the NVPO Web site.

Public attendance at the meeting is limited to space available. Individuals must provide a photo ID for entry into the Humphrey Building. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the designated contact person. Members of the public will have the opportunity to provide comments at the meeting. Public comment will be limited to five minutes per speaker. Any members of the public who wish to have printed material distributed to NVAC members should submit materials to the Executive Secretary, NVAC, whose contact information is listed above prior to close of business October 3, 2003. Preregistration is required for both public attendance and comment. Any individual who wishes to attend the meeting and/or participate in the public comment session should call the telephone number listed in the contact information to register.

The National Vaccine Program Office will be organizationally relocated to the Office of Public Health and Science on October 1. Due to administrative matters impacting this organizational relocation, this notice is being published less than 15 days in advance of the meeting.

Start Signature

Start Printed Page 56295

Dated: September 24, 2003.

Bruce G. Gellin,

Director, National Vaccine Program Office and Executive Secretary, National Vaccine Advisory Committee.